MedTrace Logo

Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

NCT05194046 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2022-01-18

No results posted yet for this study

Summary

To evaluate the effect of coadministration of amoxicillin and clarithromycin on safety, tolerability and pharmacokinetics of JP-1366 in healthy subjects and the effect of JP-1366 on safety, tolerability and pharmacokinetics of amoxicillin and clarithromycin in healthy subjects

Conditions

  • Helicobacter Pylori Associated Gastrointestinal Disease

Interventions

DRUG

JP-1366 20mg 1capsule

will be orally administered

DRUG

Amoxicillin 500Mg Cap

Amoxicilin 500Mg 2 capsules will be orally administered

DRUG

Clarithromycin 500Mg Tab

Amoxicilin 500Mg 1 tablet will be orally administered

Sponsors & Collaborators

  • Onconic Therapeutics Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-18
Primary Completion
2021-01-16
Completion
2021-01-19

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05194046 on ClinicalTrials.gov